The effect of Urtica dioica exstract on consequences of double-J ureteral catheters
Phase 1
- Conditions
- Complications of double j urethral cathater.Complications of genitourinary prosthetic devices, implants and grafts
- Registration Number
- IRCT2016090329680N1
- Lead Sponsor
- Sharoud University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
the size of the stone and the location of the stone which measures (less than ten mm) and place the stone below the junction (urethral pelvic); patients suffering a urethral stone, just on one side and those who bilateral urethral stones or kidney stones are excluded; age between 20-70 years old(due to a higher incidence of kidney stones in this age range); no history of urologic manipulation in the past few years is a another criteria.
Exclusion criteria: history of benign prostatic hypertrophy; previous surgery on the bladder or lower urinary tract; bladder stones; active urinary tract infection; lack of proper placement of the double J catheter; neurogenic bladder and the lack of the next visit.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gross hematuria. Timepoint: 3 and 7 days after start of treatment. Method of measurement: questionnaire.;Dysuria. Timepoint: 3, 7 and 15 days after start of treatment. Method of measurement: questionnaire.;Frequency. Timepoint: 3, 7 and 15 days after start of treatment. Method of measurement: questionnaire.;Pain. Timepoint: 3, 7 and 15 days after start of treatment. Method of measurement: VAS score.;Microscopic hematuria. Timepoint: 15 days after start of treatment. Method of measurement: urine analysis.;Edema and inflammation of the mucus of bladder and ureter. Timepoint: 15 days after start of treatment. Method of measurement: cystoscopy.;Urinary infection. Timepoint: 15 days after start of treatment. Method of measurement: urine cuture.;Fever. Timepoint: 3, 7 and 15 days after start of treatment. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method